A Pyrosequencing Core was approved by Research Administration and will be run by Asthma Research personnel. It is the first core managed by the division. It has a dedicated faculty member and staff member, and is located on the 8th floor of the S Building. There are external and internal marketing and public relations plans to assure that this core is advertised to a regional and national audience.
The two primary core objectives are:
1. To provide services to accurately measure DNA methylation level in a locus specific manner in a 96 well format, suitable for large-scale high-throughput validation analysis.
2. To provide services for mutation analysis and genotying, suitable for detection, and quantification or genetic variations including insertion-deletions, single nucleotide poymorphisms, single tandem repeats, and variable gene copy number.
Also, the division increased its grant, contract and award volume by 18 percent during the past year. The dollar volume rose by 10 percent. It was a superb year given that NIH and many agencies restricted the volume of grants awarded, as well as the amount of funding per award. Dr. Brandt was awarded a third year of funding on a T32 grant, which originally had a two year award period.
Dr. Melinda Butsch Kovacic was selected to attend the Association Medical Colleges Early Career Women Faculty Professional Development Seminar in Washington, DC.
Dr. Tesfaye Mersha was selected as an editor for the Frontiers in Applied Genetic Epidemiology.
Dr. Umasundari Sivaprasad was a recipient of the University of Cincinnati Research Council grant.